Brief: Valbiotis Obtains Patent For Active Substance Totum-63 In China

Valbiotis SA

19/05/2021 16:52

May 19 (Reuters) - VALBIOTIS SA  ALVAL.PA :
    * VALBIOTIS OBTAINS PATENT FOR ITS ACTIVE SUBSTANCE TOTUM-63
IN
CHINA, A LARGE POTENTIAL MARKET FOR THE PREVENTION OF TYPE 2
DIABETES AND METABOLIC DISEASES
    * WILL BENEFIT FROM EXCLUSIVE EXPLOITATION RIGHTS IN CHINA,
ONE OF
THE COUNTRIES MOST AFFECTED BY METABOLIC DISEASES IN THE WORLD
    * CHINA NATIONAL INTELLECTUAL PROPERTY ADMINISTRATION
(CNIPA) HAS
GRANTED COMPREHENSIVE PROTECTION FOR THE COMPOSITION AND USE OF
TOTUM-63 FOR THE PREVENTION OF TYPE 2 DIABETES AND METABOLIC
DISEASES
    * IS ACHIEVING ITS GLOBAL PROTECTION STRATEGY, WITH THE
TOTUM-63
PATENT NOW ACQUIRED IN NEARLY 50 COUNTRIES INCLUDING EUROPE, THE
UNITED STATES AND CHINA

Source text for Eikon:  ID:nBw2r2RM1a 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))